Literature DB >> 8564921

Chemosensitization and drug accumulation assays as complementary methods for the screening of multidrug resistance reversal agents.

A R Quesada1, M M Barbacid, E Mira, M Aracil, G Márquez.   

Abstract

Two methods based on the reversion of adriamycin-resistance o the increase of Rhodamine 123 accumulation in a multidrug resistant (MDR) cell line have been simplified and adapted for the screening of MDR reversal agents. Both methods are carried out in microtiter plates, are highly sensitive and can be easily automated. In both assays verapamil and the cyclosporine derivative PSC 833 could be detected at concentrations lower than 1 and 0.05 microM, respectively. Depending on the MDR cell line used, drugs exhibiting the collateral sensitivity phenomenon can be selected in the cytotoxicity assay, while interferences due to sample toxicity are easily avoided in the dye accumulation assay.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564921     DOI: 10.1016/0304-3835(95)04044-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  NF-κB decoy polyplexes decrease P-glycoprotein-mediated multidrug resistance in colorectal cancer cells.

Authors:  N H Abd Ellah; L Taylor; N Ayres; M M Elmahdy; G N Fetih; H N Jones; E A Ibrahim; G M Pauletti
Journal:  Cancer Gene Ther       Date:  2016-04-29       Impact factor: 5.987

2.  Rapid assessment of P-glycoprotein inhibition and induction in vitro.

Authors:  Michael D Perloff; Elke Störmer; Lisa L von Moltke; David J Greenblatt
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

3.  Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.

Authors:  A R Quesada; M D García Grávalos; J L Fernández Puentes
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

4.  Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein.

Authors:  G Lehne; H E Rugstad
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.